Physicians face barriers to care for patients with cancer
the ONA take:
Patients are not alone in facing barriers to care. Many physicians also report encountering barriers when referring patients with cancer to specialty care.
Researchers from the David Geffen School of Medicine at the University of California in Los Angeles analyzed responses to the Cancer Care Outcomes Research and Surveillance Consortium physician survey.
They found that 3 in 5 physicians reported always, usually, or sometimes encountering any barrier to specialty referrals for patients with cancer.
Barriers included health insurance-related factors (eg, restricted provider networks, preauthorization requirements), patient-related issues (inability to pay, excessive travel time), and a lack of surgical subspecialists.
Higher barrier scores were found among international medical graduates, physicians practicing in certain types of practices, and those with less than 90% of their patients in managed care plans. In addition, higher barrier scores were also tied to lower physician career satisfaction among both primary care physicians and specialists.
Many physicians report encountering barriers when referring patients with cancer to specialty care.
Sign Up for Free e-newsletters
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Sexual Aids and Resources Not Readily Available at Cancer Centers
- Factors Affecting Employment Participation in Early-stage Breast Cancer
- 5-Year Overall Survival in Endometrial Cancer Not Improved With Chemoradiotherapy
- Gas Mixture Improves Efficacy of Breakthrough Cancer Pain Treatment
- Sitting With Silence in End-of-Life Cancer Care
- Obesity and Cancer Risk (Fact Sheet)
- Susceptibility Gene Mutations Common in Those With Pancreatic Cancer and History of Other Cancers
- Anticancer Properties of Omega-3 Fatty Acids: Plant-Based vs Marine-Based
- US Pharmacopeia Revises Chapter on Handling Hazardous Drugs
- Follow-Up After Treatment Lacking for Younger Cancer Survivors
- Adjuvant Vemurafenib Does Not Improve Disease-Free Survival in Melanoma
- Profile of Buparlisib and its Potential in the Treatment of Breast Cancer: Evidence to Date
- Exercise Before Lung Cancer Surgery Greatly Reduces Complications
- Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|